- Home
- BMRA vs ADXN Comparison
BMRA vs ADXN Comparison
Compare BMRA & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- ADXN
- Stock Information
- Founded
- BMRA 1971
- ADXN 2002
- Country
- BMRA United States
- ADXN Switzerland
- Employees
- BMRA N/A
- ADXN N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- BMRA Health Care
- ADXN Health Care
- Exchange
- BMRA Nasdaq
- ADXN Nasdaq
- Market Cap
- BMRA 8.2M
- ADXN 8.0M
- IPO Year
- BMRA N/A
- ADXN N/A
- Fundamental
- Price
- BMRA $2.92
- ADXN $10.85
- Analyst Decision
- BMRA
- ADXN Strong Buy
- Analyst Count
- BMRA 0
- ADXN 1
- Target Price
- BMRA N/A
- ADXN $30.00
- AVG Volume (30 Days)
- BMRA 425.8K
- ADXN 61.3K
- Earning Date
- BMRA 10-14-2025
- ADXN 09-01-2025
- Dividend Yield
- BMRA N/A
- ADXN N/A
- EPS Growth
- BMRA N/A
- ADXN N/A
- EPS
- BMRA N/A
- ADXN 0.10
- Revenue
- BMRA $5,311,000.00
- ADXN $278,508.00
- Revenue This Year
- BMRA N/A
- ADXN $86.57
- Revenue Next Year
- BMRA N/A
- ADXN N/A
- P/E Ratio
- BMRA N/A
- ADXN $0.84
- Revenue Growth
- BMRA N/A
- ADXN N/A
- 52 Week Low
- BMRA $2.08
- ADXN $6.51
- 52 Week High
- BMRA $10.16
- ADXN $12.05
- Technical
- Relative Strength Index (RSI)
- BMRA 43.27
- ADXN 68.95
- Support Level
- BMRA $2.87
- ADXN $8.88
- Resistance Level
- BMRA $3.08
- ADXN $12.05
- Average True Range (ATR)
- BMRA 0.21
- ADXN 0.47
- MACD
- BMRA 0.01
- ADXN 0.28
- Stochastic Oscillator
- BMRA 54.93
- ADXN 72.41
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.